NEW YORK and NEWPORT BEACH, Calif.

纽约和加利福尼亚州纽波特比奇

,

，

March 31, 2026

2026年3月31日

/PRNewswire/ --

/PRNewswire/ --

MedReview

医学评论

, a leader in payment integrity solutions for health insurers, is proud to announce the acquisition of

，一家为健康保险公司提供支付完整性解决方案的领导者，自豪地宣布收购了

Vital Data Technology

生命数据技术

, the premier provider of advanced healthcare payer workflow and data technology. This strategic acquisition strengthens and expands MedReview's comprehensive payer solution suite by adding member outcome-focused solutions.

，领先的高级医疗支付方工作流程和数据技术提供商。此次战略性收购通过增加以成员结果为导向的解决方案，加强并扩展了MedReview全面的支付方解决方案套件。

Continue Reading

继续阅读

Founded in 2005, Vital Data Technology transforms the healthcare ecosystem by empowering stakeholders with predictive insights to improve member health and lower costs. The company's AI-driven intelligent analytics platform, Affinitē, promotes health plans' abilities to make faster and better decisions in real-time to improve care management, quality, population health, and risk adjustment.

成立于2005年，Vital Data Technology通过为利益相关者提供预测性洞察来改善会员健康并降低成本，从而变革了医疗保健生态系统。该公司基于人工智能的智能分析平台Affinitē提升了健康计划的能力，使其能够实时做出更快、更好的决策，以改进护理管理、质量、人群健康和风险调整。

The acquisition underscores MedReview's continued focus on creating innovative and impactful solutions to support healthcare payers..

此次收购突显了MedReview持续专注于创建创新且有影响力的解决方案，以支持医疗支付方。

MedReview has acquired Vital Data Technology, expanding their comprehensive payer solution suite.

MedReview 收购了 Vital Data Technology，扩展了其全面的支付方解决方案套件。

Post this

发布这个

'This acquisition represents an important step forward in our long‑term strategy,' said Spencer Young, CEO of MedReview. 'By bringing these two organizations together, we strengthen our collective ability to deliver greater value to the clients of both organizations while expanding our capabilities in ways that position us well for the future.

“这次收购代表了我们长期战略的重要一步，”MedReview首席执行官斯宾塞·杨表示。“通过将这两个组织结合在一起，我们增强了为两个组织的客户创造更大价值的综合能力，同时拓展了我们的业务能力，使我们为未来的发展奠定了良好的基础。”

We are excited about the opportunities ahead and about welcoming an exceptional team into our organization.'.

我们对未来的机会感到兴奋，并期待将一支卓越的团队引入我们的组织。

Vital Data will operate as a wholly-owned subsidiary of MedReview. 'We're pleased to find a complementary business partner who shares our commitment to increasing the quality of care, successful patient outcomes, and measurable waste reduction,' said Matt D'Ambrosia, CEO of Vital Data Technology. 'Joining forces with MedReview advances Vital Data's ability to achieve our mission and enable payers to act with confidence.'.

Vital Data将作为MedReview的全资子公司运营。Vital Data Technology首席执行官Matt D'Ambrosia表示：“我们很高兴找到一个与我们致力于提高护理质量、实现患者成功康复和可衡量的浪费减少相契合的业务合作伙伴。与MedReview联手增强了Vital Data实现使命的能力，并使支付方能够充满信心地采取行动。”

Gail Donovan, Chairperson of the Board for MedReview, said of the acquisition, 'The addition of Vital Data's technology and talent to the MedReview family is rooted in a shared vision for innovation and delivering greater value to our healthcare payer partners.'

MedReview董事会主席盖尔·多诺万在谈及此次收购时表示：“Vital Data的技术和人才加入MedReview大家庭，是基于我们对创新的共同愿景，并为我们的医疗支付合作伙伴提供更大的价值。”

Terms of the transaction were not disclosed. Synergy Advisors served as financial advisor and Goodwin served as legal advisor to MedReview. Bailey & Company served as financial advisor and Sheppard served as legal advisor to Vital Data Technology.

交易条款未披露。Synergy Advisors 担任 MedReview 的财务顾问，Goodwin 担任其法律顾问。Bailey & Company 担任 Vital Data Technology 的财务顾问，Sheppard 担任其法律顾问。

About MedReview

关于MedReview

MedReview has over 50 years of experience delivering physician-approved pre-pay and post-pay payment integrity services that prioritize billing and payment quality, accuracy, and precision. Every claim reassigned by MedReview is reviewed, approved, and documented by a team of physicians, resulting in the industry's lowest appeal overturn rate.

MedReview 拥有超过 50 年的经验，提供经医生批准的支付前和支付后付款完整性服务，优先确保账单和付款的质量、准确性和精确性。MedReview 重新分配的每项索赔都由医生团队进行审核、批准和记录，因此其上诉推翻率在业内最低。

It offers a full spectrum of payment integrity solutions, including DRG and clinical reviews, cost outlier audits, re-admission reviews, data mining, and itemized bill reviews, which collectively save hundreds of millions of dollars in overpayment prevention and recovery annually. For more information, please visit: .

它提供了一整套支付完整性解决方案，包括DRG和临床审查、成本异常审计、再入院审查、数据挖掘和明细账单审查，这些方案共同每年在防止和追回超额支付方面节省了数亿美元。欲了解更多信息，请访问：。

https://www.medreview.us/

https://www.medreview.us/

About Vital Data Technology

关于Vital Data Technology

Vital Data Technology is a data science-driven healthcare solutions company giving payers, providers, and members the power to drive efficiencies and improve clinical and financial outcomes throughout the healthcare ecosystem with its proprietary artificial intelligence-enabled platform, Affinitē. This cloud-based, end-to-end solution transforms data into actionable insights using artificial intelligence and advanced analytics integrated with embedded HEDIS.

Vital Data Technology是一家以数据科学为驱动的医疗解决方案公司，其专有的人工智能平台Affinitē赋予支付方、服务提供方和会员在整个医疗生态系统中提升效率、改善临床和财务成果的能力。这个基于云的端到端解决方案通过人工智能和高级分析与嵌入式HEDIS相结合，将数据转化为可操作的洞察。

®

®

and risk adjustment logic.

和风险调整逻辑。

https://vitaldatatechnology.com/

https://vitaldatatechnology.com/

SOURCE MedReview

来源：MedReview

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示